Cargando…

Evaluation of serum interferons in patients with age-related macular degeneration

BACKGROUND: Environmental, genetic, and immunological factors may play a role in the pathogenesis of age-related macular degeneration (AMD). In an attempt to better understand the pathogenesis of AMD, in this study, we evaluated the serum interferon (IFN) levels in patients with AMD and compared it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afarid, Mehrdad, Azimi, Ali, Malekzadeh, Mahyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450131/ https://www.ncbi.nlm.nih.gov/pubmed/31007694 http://dx.doi.org/10.4103/jrms.JRMS_363_18

Ejemplares similares

Intravitreal Injection of Bevacizumab: Review of our previous Experience
por: Afarid, Mehrdad, et al.
Publicado: (2018)

Thyroidopathy and Age-Related Macular Degeneration: Is There Any Correlation
por: Chatziralli, Irini, et al.
Publicado: (2017)

Risk of Parkinson’s disease in patients with neovascular age-related macular degeneration
por: Etminan, Mahyar, et al.
Publicado: (2018)

Serum lipids in adults with late age-related macular degeneration: a case-control study
por: Semba, Richard D., et al.
Publicado: (2019)

Genetic screening for macular dystrophies in patients clinically diagnosed with dry age‐related macular degeneration
por: Kersten, Eveline, et al.
Publicado: (2018)

Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration
por: Zakaria, Nadia, et al.
Publicado: (2022)

Projected changes in age-related macular degeneration and driving license holders in Finland
por: Viitanen, Olli, et al.
Publicado: (2014)

P38 MAPK Signaling in the Retina: Effects of Aging and Age-Related Macular Degeneration
por: Muraleva, Natalia A., et al.
Publicado: (2023)

Serum Autoantibodies in Patients with Dry and Wet Age-Related Macular Degeneration
por: Korb, Christina A., et al.
Publicado: (2023)

Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration
por: Pujol-Lereis, Luciana M., et al.
Publicado: (2018)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Identification of Novel Serum MicroRNAs in Age-Related Macular Degeneration
por: ElShelmani, Hanan, et al.
Publicado: (2020)

Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
por: Panos, Georgios D, et al.
Publicado: (2013)

Rescue effects of intravitreal aflibercept in the treatment of neovascular age-related macular degeneration
por: Hsia, Ning-Yi, et al.
Publicado: (2015)

Glycolysis in Patients with Age-Related Macular Degeneration
por: Yokosako, Kanako, et al.
Publicado: (2014)

Interferon-γ in the serum and effusions of cats with feline coronavirus infection
por: Giordano, Alessia, et al.
Publicado: (2009)

Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
por: Keles, Sadullah, et al.
Publicado: (2014)

Alterations in Faecal and Serum Metabolic Profiles in Patients with Neovascular Age-Related Macular Degeneration
por: Yuan, Qixian, et al.
Publicado: (2023)

Incorporating prior knowledge to facilitate discoveries in a genome-wide association study on age-related macular degeneration
por: Lin, Wan-Yu, et al.
Publicado: (2010)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Angiogenin in age-related macular degeneration
por: Skeie, Jessica M., et al.
Publicado: (2011)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Age-Related Macular or Retinal Degeneration?
por: Gałuszka, Michalina, et al.
Publicado: (2023)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Age-Related Macular Degeneration and the Aging Brain
por: Whitson, Heather, et al.
Publicado: (2021)

Evaluation of vascular endothelial growth factor (VEGF) level in the tears and serum of age-related macular degeneration patients
por: Shahidatul-Adha, Mohamad, et al.
Publicado: (2022)

Evaluation of variants in the selectin genes in age-related macular degeneration
por: Mullins, Robert F, et al.
Publicado: (2011)

Evaluation of real-world mobility in age-related macular degeneration
por: Sengupta, Sabyasachi, et al.
Publicado: (2015)

Serum 25-hydroxy vitamin D levels in age-related macular degeneration
por: Pérez Serena, Antonio, et al.
Publicado: (2022)

SIRT1: Genetic Variants and Serum Levels in Age-Related Macular Degeneration
por: Kaikaryte, Kriste, et al.
Publicado: (2022)

Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration
por: MIRSHAHI, Ahmad, et al.
Publicado: (2017)

Effect of Supplemental Lutein and Zeaxanthin on Serum, Macular Pigmentation, and Visual Performance in Patients with Early Age-Related Macular Degeneration
por: Huang, Yang-Mu, et al.
Publicado: (2015)

LAMELLAR MACULAR HOLES IN THE PRESENCE OF AGE-RELATED MACULAR DEGENERATION
por: Francone, Anibal, et al.
Publicado: (2020)

Gait Characteristics of Age-Related Macular Degeneration Patients
por: Varadaraj, Varshini, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_re0tluf1a3ae7m99c8h0e7nhti